Severe Legionnaires disease complicated by multi-organ dysfunction in a previously healthy patient: a case report by Kassha, Kays et al.
BioMed  Central
Page 1 of 3
(page number not for citation purposes)
Cases Journal
Open Access Case Report
Severe Legionnaires disease complicated by multi-organ 
dysfunction in a previously healthy patient: a case report
Kays Kassha*1, Issam Abuanza2, Samer A Hadi3 and Roy Hilton2
Address: 1Surgical Department, Glan Clwyd Hospital, Rhuddlan Road, Rhyl, LL18 5UJ, UK, 2A&E Department, Glan Clwyd Hospital, Rhuddlan 
Road, Rhyl, LL18 5UJ, UK and 3Medical Department (COTE) Glan C lwyd Hospital, Rhuddlan Road, Rhyl, LL18 5UJ, UK
Email: Kays Kassha* - kays.kassha@doctors.org.uk; Issam Abuanza - essam_abuanza@yahoo.com; Samer A Hadi - dr.samer1@yahoo.com; 
Roy Hilton - Roy.hilton@cd-tr.wales.nhs.uk
* Corresponding author    
Abstract
A case of a previously healthy lady with community-acquired pneumonia who progressed to severe
acute respiratory distress syndrome, acute renal failure, disseminated intravascular coagulation and
sepsis is reported. Treatment with antibiotics and various modes of mechanical ventilation in the
intensive care unit were successful. A urinary legionella antigen test was positive for Legionella
pneumophila.
Introduction
Legionella is a cause of both community and nosocomial
pneumonia. A recent study found that it accounted for 2
to 9% of community-acquired pneumonia. Unless anti-
Legionella  antibiotics are selected, the mortality of
legionellosis has been reported to be 60-70%; the use of
appropriate antibiotics decreases mortality to 10-20%. We
report a case of severe Legionella pneumonia that was suc-
cessfully treated with antibiotics, corticosteroid and vari-
ous modes of mechanical ventilation in the intensive care
unit.
Case presentation
A 58-year-old white Caucasian British lady, came to the
emergency department with a 2 day history of high fever
(38.6°C) shortness of breath, productive cough and diar-
rhoea 3 days after she had arrived from New Jersey.
In the emergency department, her respiratory rate was 21/
min, blood pressure 88/57 mmHg, and heart rate 116/
min and regular and Arterial oxygen saturation was 77%
on room air and increased to 90% on 100% oxygen via a
face mask. Rales were present in one third of the lung
fields bilaterally and Percussion revealed dullness at the
base of the right lung, with poor air entry in the right
lower base. Additionally, her blood gas results were her
blood gas results were, pH: 7.49, PaO2: 4.9 mmHg,
PaCO2: 3.8 mmHg, HCO-3: 24 mM, BE: -0.5 mM and
SaO2 77%. Her CURB score surprisingly was 1, one point
for Low blood pressure.
A chest radiograph showed extensive consolidation
present throughout the right lung (Figure 1) and there was
also a little patchy consolidation in the left mid and lower
zones.
Due to septic shock, acute respiratory distress syndrome
and disseminated intravascular coagulation The patient
was admitted to the ITU and she was placed on CPAP ini-
tially and inotropes were started. The patient's hypoxemia
increased, and there was marked progression of the bilat-
eral shadows on chest X-ray, suggestive of ARDS. Hence,
the patient was placed on mechanical ventilation, steroid
infusion and an antibiotic regime of clarithromycin,
ceftriaxone, rifampicin and clindamycin commenced.
Because she did not show any signs of improvement, she
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was transferred to another hospital for ECMO (Extracor-
poreal membrane oxygenation), which she had for 5 days.
On hospital day 6, her urine output was low and so she
was put on RRT (Renal replacement therapy).
On the seventh day after admission, Legionella antigen was
detected in the urine, the diagnosis of Legionella pneumo-
nia was confirmed. Also, Bacteriological examination of
sputum disclosed Legionella pneumophila. All her antibiot-
ics were stopped except ceftriaxone, and she was contin-
ued on prednisolone for 3 more weeks.
After the 21st hospital day, the radiographic findings grad-
ually improved, the patient was taken off the ventilator
and placed on CPAP. Moreover, her kidney functions
recovered and RRT was stopped and she was moved to a
respiratory ward, where she remained for another 4 weeks
during which she had nutritional and physiotherapy sup-
port. The lady was discharged with almost full range of
mobility and independency in day 70th. Table 1 shows the
clinical course of the present case.
Discussion
Legionnaire's disease is due to L pneumophila, which
causes an atypical pneumonia. The natural habitat for L
pneumophila is fresh water or protozoan biofilms, in which
the bacteria parasitize and proliferate inside the protozoa.
Once the water is transferred into man-made water reser-
voirs, the Legionella  organisms proliferate. Legionella  is
transmitted to humans via inhalation of colonized aero-
sols or droplets, which are produced by air conditioners,
cooling towers and condensers, water fountains, shower
heads, faucets, whirlpools, ice machines, spas, nebulizers,
and humidifiers. Advanced age, immunocompromised
state, cigarette smoking, chronic lung disease, and male
sex are all risk factors for Legionnaire's disease [1].
Clinical manifestations
The signs and symptoms are nonspecific and are similar to
those of an atypical pneumonia, but more severe. The
incubation period is 2 to 10 days; during this time, the
signs and symptoms are typically mild. The cough at first
is mild and only slightly productive. symptoms are often
prominent with diarrhea, nausea, vomiting, and abdomi-
nal pain. Examination of the lungs may initially reveal
focal rales that will eventually become diffuse. Findings
on an initial radiograph of the chest may be normal, but
eventually a pulmonary infiltrate will develop [2,3].
￿ Cough - 41 to 92 percent
￿ Chills - 42 to 77 percent
￿ Fever > 38.8°C - 88 to 90 percent
￿ > 40°C - 20 to 62 percent
￿ Dyspnea - 25 to 62 percent
￿ Headache - 40 to 48 percent
￿ Myalgia/arthralgia - 20 to 40 percent
￿ Diarrhea - 21 to 50 percent
￿ Nausea/vomiting - 8 to 49 percent
￿ Neurologic abnormalities - 4 to 53 percent
￿ Chest pain - 13 to 35 percent
Chest X-ray on admission which showed right lower lobe  consolidation' Figure 1
Chest X-ray on admission which showed right lower 
lobe consolidation'.
Table 1: Biochemistry
Blood Tests Day1 Day2 Day10 Day15 Day20 Day30 Day45 Day60 Day70 Day75
Wcc 1.6 20.3 11.4 5 4.8 8.5 11.2 9.1 14.8 10.5
Urea 8.5 7.4 15.1 21.4 17.6 8.9 3.9 2.1 2.6 2Publish with BioMed Central    and   every 
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Diagnosis
Four tests are predominantly used: culture of specimens,
direct fluorescent antibody test, urine antigen test, and
serum antibody assay. The urine antigen test is highly spe-
cific, provides rapid results, and is particularly useful
because the fact that test positivity can persist for days
even during administration of antibiotic. The major dis-
advantage of the urinary antigen test is that it is specific for
L. pneumophila, serogroup 1 only. However, the vast
majority of Legionnaires' disease cases from the commu-
nity are caused by this species and serogroup. specifity of
suptum culture is high, however, obtaining an adequate
sputum specimen can be difficult. The test for serum anti-
bodies to Legionella has a high specificity, but the lowest
sensitivity, in part because a 4-fold increase in antibody
levels is necessary for detection of the antibodies. Addi-
tionally, an antibody response may not be detectable until
after 4 to 12 weeks of infection. DNA amplification by
polymerase chain reaction (PCR) of Legionella has been
reported from patients with pneumonia using throat swab
specimens, bronchoalveolar lavage (BAL), urine, and
serum. To date, clinical experience has not shown PCR to
be more sensitive than culture, and therefore the Centers
for Disease Control and Prevention (CDC) does not rec-
ommend the routine use of genetic probes or PCR for the
detection of Legionella in clinical samples [4-6].
Treatment
The treatment of community-acquired pneumonia with-
out the benefit of diagnostic testing should include
empiric treatment for infections caused by several micro-
organisms, including Legionella  species. The American
Thoracic Society and Infectious Diseases Society of Amer-
ica consensus committees on community-acquired pneu-
monia recommend empiric therapy with azithromycin,
either as monotherapy or combined with a β-lactam
agent. Monotherapy with a respiratory quinolone such as
levofloxacin also is acceptable [7,8].
Patient's perspective
''Started with sever Flu-like symptoms in mid-September,
remember nothing until mid- October. Loss of use of
limbs continues with tracheotomy made situation very
frightening. However, mostly recovered apart from weak-
ness of limbs generally. On- going stomach problems still
to be investigated by the GP. My thanks to staff a Glan
Clwyd Hospital and at Leicester (ECHO machine) who
probably saved my life".
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